Merkel Cell Carcinoma — Trials

Merkel Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

133 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 51
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05013099	Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies(iPREDICT)	unknown	Phase 2	70	ImaginAb, Inc.INDUSTRY	6	Jul 22, 2024	clinicaltrials
NCT05329792	L19IL2/L19TNF in Skin Cancer Patients(IntriNSiC)	unknown	Phase 2	70	Philogen S.p.A.INDUSTRY	3	Oct 6, 2023	clinicaltrials